Jae Myung Cha

Dr. Jae Myung Cha

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2019 in Gut and Liver
Verified
Journal Article
Open access
PDF file
JMJun Ki Min
Jun Ki Min
MKMin Seob Kwak
Min Seob Kwak
JCJae Myung Cha
Jae Myung Cha
Jun Ki Min, Min Seob Kwak, and Jae Myung Cha. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl18384

16 November 2018 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MKMin Seob Kwak
Min Seob Kwak
JCJae Myung Cha
Jae Myung Cha
HLHun Hee Lee
Hun Hee Lee
YCYong Sung Choi
Yong Sung Choi
SSSeung In Seo
Seung In Seo
TKTae Jun Kim
Tae Jun Kim

9 September 2019 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
CLChang Kyun Lee
Chang Kyun Lee
HHHyo Jung Ha
Hyo Jung Ha
SOShin Ju Oh
Shin Ju Oh
JKJung-Wook Kim
Jung-Wook Kim
JLjungkuk lee
jungkuk lee
HKHyo Jong Kim
Hyo Jong Kim

7 June 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
JYJin Young Yoon
Jin Young Yoon
JCJae Myung Cha
Jae Myung Cha
JOJu Kyoung Oh
Ju Kyoung Oh
PTPei Lei Tan
Pei Lei Tan
SKSae hun Kim
Sae hun Kim
HSHYUN PHIL SHIN
HYUN PHIL SHIN

1 January 2015 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
DKDong Hyun Kim
Dong Hyun Kim
JCJae Myung Cha
Jae Myung Cha
HSHYUN PHIL SHIN
HYUN PHIL SHIN
KJKwang Ro Joo
Kwang Ro Joo
JLJoung Il Lee
Joung Il Lee
DPDong Il Park
Dong Il Park
To develop and validate a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea. Colorectal advanced neoplasia is the relevant finding of screening colonoscopy. Risk estimation for advanced neoplasia may be helpful to improve compliance and to develop more cost-effective approaches toward screening. We developed Korean Colorectal Screening (KCS) score by optimizing and adjusting Asia-Pacific Colorectal Screening (APCS) score to predict advanced neoplasia in an asymptomatic Korean population who received screening colonoscopies from September 2006 to September 2009. Moreover, we validated the KCS score in another Korean cohort who received screening colonoscopies from October 2009 to February 2011. We also assessed the predictive power and diagnostic performance of both KCS and APCS scores. There were 3561 subjects in the derivation cohort and 1316 subjects in the validation cohort, with a prevalence of advanced neoplasia of 4.7% and 4.3%, respectively. After a multivariate analysis, KCS was developed as 0 to 8 points comprising of age, sex, body mass index, smoking, and family history of CRC. Using KCS scores to stratify the validation cohort, the prevalences of advanced neoplasia in the 3 risk tiers (average, moderate, and high) were 2.0%, 3.7%, and 10.9%, respectively. Moderate-risk and high-risk tiers showed 2.1- and 6.5-fold increased prevalences, respectively, of advanced neoplasia compared with average risk tier. In addition, KCS score showed relatively good discriminative power (ROC=0.681) and higher sensitivity compared with APCS score for the high-risk tier. KCS score may be clinically simple and useful for assessing advanced neoplasia risk in Korea. However, racial disparity should be considered in risk stratification-based screening in each country.

15 March 2019 in Gut and Liver
Verified
Journal Article
Open access
PDF file
MKMin Seob Kwak
Min Seob Kwak
JCJae Myung Cha
Jae Myung Cha
HYHyo-Joon Yang
Hyo-Joon Yang
DPDong Il Park
Dong Il Park
KKKyeong Ok Kim
Kyeong Ok Kim
HKHyun Gun Kim
Hyun Gun Kim
Min Seob Kwak, Jae Myung Cha, Hyo-Joon Yang, Dong Il Park, Kyeong Ok Kim, Jun Lee, Jeong Eun Shin, Young-Eun Joo, Jongha Park, Jeong-Sik Byeon, Hyun Gun Kim; Intestinal Cancer Study Group of the Korean Association for the Study of Intestinal Diseases (KASID). Gut and Liver 1999;0:. https://doi.org/10.5009/gnl18214